Clinical Trial Details

EORTC-30923

Back to Clinical Trials Database

Phase II trial of the efficacy and safety of roquinimex (linomide) in the treatment of renal cell carcinoma

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 24-Feb-1993
Date Step1 close: 30-Sep-1994
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 40
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/
NCT number